Aurora Cannabis may be the industry's top producer, but these three marijuana stocks are expected to generate more in sales next year.
News & Analysis: Curaleaf Holdings, Inc.
Four of the five largest cannabis deals have crossed the billion-dollar mark.
While these nine pot stocks rose, 38 others ended lower by at least 10%.
The U.S. Food and Drug Administration's harsh stance on cannabidiol should surprise no one.
Are these historically anti-cannabis states turning over a new leaf?
Curaleaf's $875 million deal to buy Grassroots shakes up the multistate dispensary leaderboard.
Curaleaf is buying expansion with its $875 acquisition of Grassroots. Meanwhile, OrganiGram reported Q3 results, and Aurora Cannabis had a good news/bad news week.
CRISPR Therapeutics and Curaleaf Holdings could have a lot more room to run.
The company will be the new owner of GR Companies (Grassroots).
Wall Street saw another quiet start to the session on Wednesday morning.